Sulindac
Back to searchMolecule Structure
Scientific Name
Sulindac
Description of the Drug
Sulindac is an NSAID used to treat osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute subacromial bursitis or supraspinatus tendinitis, and acute gouty arthritis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00605
http://www.drugbank.ca/drugs/DB00605
Brand Name(s)
Clinoril, Sulindac
Company Owner(s)
Epic Pharma Llc, Fosun Pharma Usa Inc, Merck Research Laboratories Div Merck Co Inc, Sun Pharmaceutical Industries Inc, Watson Laboratories Inc, Ani Pharmaceuticals Inc, Rising Pharma Holdings Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Cyclooxygenase | PROTEIN FAMILY | INHIBITOR | CHEMBL2094253 |
Clinical Trial(s)
Unichem Links
Atlas | sulindac | ||
SureChEMBL | SCHEMBL4202 | ||
Human Metabolome Database | HMDB0014743 | ||
DrugBank | DB00605 | ||
PubChem: Thomson Pharma | 14828051 | ||
PubChem | 1548887 | ||
LINCS | LSM-43065 | ||
Nikkaji | J3.501G | ||
BindingDB | 50012899 | 50103504 | |
EPA CompTox Dashboard | DTXSID4023624 | ||
DrugCentral | 2534 | ||
Brenda | 104047 | 2172 | 172615 |
ChemicalBook | CB3740374 | ||
Guide to Pharmacology | 5425 | ||
rxnorm | SULINDAC | ||
KEGG Ligand | C01531 | ||
ChEBI | 9352 |